535 related articles for article (PubMed ID: 24729185)
1. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
2. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
[TBL] [Abstract][Full Text] [Related]
3. Previous head and neck cancers portend poor prognoses in lung cancer patients.
Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
[TBL] [Abstract][Full Text] [Related]
4. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
[TBL] [Abstract][Full Text] [Related]
5. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?
Lee P; de Bree R; Brokx HA; Leemans CR; Postmus PE; Sutedja TG
Lung Cancer; 2008 Dec; 62(3):309-15. PubMed ID: 18486989
[TBL] [Abstract][Full Text] [Related]
6. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
7. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
Jung YS; Lim J; Jung KW; Ryu J; Won YJ
PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
[TBL] [Abstract][Full Text] [Related]
8. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
9. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
10. Second cancer incidence and risk factors in patients with salivary gland cancers.
Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
[TBL] [Abstract][Full Text] [Related]
11. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
Atienza JA; Dasanu CA
Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
Chuang SC; Scelo G; Tonita JM; Tamaro S; Jonasson JG; Kliewer EV; Hemminki K; Weiderpass E; Pukkala E; Tracey E; Friis S; Pompe-Kirn V; Brewster DH; Martos C; Chia KS; Boffetta P; Brennan P; Hashibe M
Int J Cancer; 2008 Nov; 123(10):2390-6. PubMed ID: 18729183
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Yamashita T; Araki K; Tomifuji M; Tanaka Y; Harada E; Suzuki T; Miyamoto S; Shiotani A
Asia Pac J Clin Oncol; 2017 Jun; 13(3):172-178. PubMed ID: 27783469
[TBL] [Abstract][Full Text] [Related]
14. Secondary primary cancer in patients with head and neck carcinoma: the differences among hypopharyngeal, laryngeal, and other sites of head and neck cancer.
Liu WS; Chang YJ; Lin CL; Liang JA; Sung FC; Hwang IM; Kao CH
Eur J Cancer Care (Engl); 2014 Jan; 23(1):36-42. PubMed ID: 23782223
[TBL] [Abstract][Full Text] [Related]
15. Survival in patients with metachronous second primary lung cancer.
Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
[TBL] [Abstract][Full Text] [Related]
16. Second course of radiation for new primary head-and-neck cancer: population-based study of survival.
Milano MT; Zhang H
Am J Clin Oncol; 2011 Aug; 34(4):367-71. PubMed ID: 20859195
[TBL] [Abstract][Full Text] [Related]
17. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
[TBL] [Abstract][Full Text] [Related]
18. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
19. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.
Yesensky J; Kyrillos A; Kuchta K; Yao K; Wang CH; Bhayani MK
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):303-308. PubMed ID: 29039234
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
